The Toronto, Canada – based wellness company announced plans to purchase 4 brands from EMMAC Life Sciences Group in exchange for shares of Yooma, equivalent to $8.1m US dollars.
EMMAC Life Sciences Group, a London, England – based cannabis company, itself acquired Blossom in late January 2019. Blossom is a CBD wellness brand with topical skin care, ingestible oils, and teas in its product portfolio
CosmeticsDesign.com first reported on the ingredient supplier’s research around CBD derivatives and silicone gel elastomers following the 2019 SCC Annual Meeting and Technology Showcase. Now that research is a reality, with the launch of a personal care ingredient called Vertasil TM-CBD1.
CBD is not compatible with silicone substrates. And that’s the challenge Gelest set out to address. The ingredient maker specializes in silanes, silicones, and metal-organics for the medical, pharmaceutical, and personal care industries (as well as others).
The cannabis company, with a specialty in indoor cultivation, has just commercialized 6 CBD skin care products for sale in Latin America.
“We are proud to have completed this major milestone and have positioned ourselves to be a leader and cornerstone of product quality within the global marketplace, with an initial emphasis in Latin America and Europe.” Borja Sanz de Madrid, President of Ikänik Farms International, Inc., tells the press.
Personal care giant Colgate-Palmolive has developed three active oral care formulas that integrate a cannabinoid, namely cannabidiol (CBD), for antibacterial efficacy and anti-inflammatory action.
Writing in three separate international patents (I, II & III), Colgate-Palmolive said it had created different oral care compositions comprising a cannabinoid, in particular CBD, integrated with an orally acceptable carrier. These blends, it said, could be used to make a range of oral care products, including toothpaste, mouthwash, oral gels, chewing gum and mouth spray, among others.Read more...
A Canadian CBD cosmetics, supplements and medical cannabis product company has received an important license from the government of Colombia, where its grow operations are located.
Flora Growth Inc, which is based in Toronto and whose stock is traded on the NASDAQ exchange, reported yesterday that is has received permission from the Colombian government to export as much a 7,900 kg of high THC cannabis flower. Flora Growth has already been growing high CBD industrial hemp crops outdoors in Colombia, but has been preparing for entry into the medical cannabis markets as well.
